CoChat

SARS‐CoV‐2 re‐infection risk in Austria

Open access
Pilz, Stefan, Chakeri, Ali, Ioannidis, John PA, Richter, Lukas, Theiler‐Schwetz, Verena, Trummer, Christian, Krause, Robert, Allerberger, Franz · 2021 · European Journal of Clinical Investigation
Cited by 152

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: A key question concerning coronavirus disease 2019 (COVID‐19) is how effective and long lasting immunity against this disease is in individuals who were previously infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We aimed to evaluate the risk of SARS‐CoV‐2 re‐infections in the general population in Austria. Methods: This is a retrospective observational study using national SARS‐CoV‐2 infection data from the Austrian epidemiological reporting system. As the primary outcome, we aim to compare the odds of SARS‐CoV‐2 re‐infections of COVID‐19 survivors of the first wave (February to April 30, 2020) versus the odds of first infections in the remainder general population by tracking polymerase chain reaction (PCR)‐confirmed infections of both groups during the second wave from September 1 to November 30, 2020. Re‐infection counts are tentative, since it cannot be excluded that the positive PCR in the first and/or second wave might have been a false positive. Results: We recorded 40 tentative re‐infections in 14 840 COVID‐19 survivors of the first wave (0.27%) and 253 581 infections in 8 885 640 individuals of the remaining general population (2.85%) translating into an odds ratio (95% confidence interval) of 0.09 (0.07 to 0.13). Conclusions: We observed a relatively low re‐infection rate of SARS‐CoV‐2 in Austria. Protection against SARS‐CoV‐2 after natural infection is comparable with the highest available estimates on vaccine efficacies. Further well‐designed research on this issue is urgently needed for improving evidence‐based decisions on public health measures and vaccination strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/eci.13520

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 152

Metadata

Authors
Pilz, S., Chakeri, A., Ioannidis, J. P., Richter, L., Theiler‐Schwetz, V., Trummer, C., Krause, R., & Allerberger, F.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2021-02-21
Volume
51
Issue
4
Pages
e13520-e13520
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W3131501116
Cited by
152
References
9
FWCI
10.59
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS‐CoV‐2 re‐infection risk in Austria. https://app.cochat.ai/papers/10.1111/eci.13520
The paper
Pilz, S., Chakeri, A., Ioannidis, J. P., Richter, L., Theiler‐Schwetz, V., Trummer, C., Krause, R., & Allerberger, F. (2021). SARS‐CoV‐2 re‐infection risk in Austria. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.13520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.